First published 9/28/2026, 9:49:15 AM · Last updated 9/28/2026, 9:49:15 AM

Pathological complete response achieved in a patient with initially unresectable locally advanced esophageal squamous cell carcinoma via conversion therapy combining immunotherapy and chemotherapy: a case report

A journal case report describes a patient with initially unresectable locally advanced esophageal squamous cell carcinoma who achieved a pathological complete response after conversion therapy combining immunotherapy and chemotherapy. The provided excerpt only lists the publisher and content type and contains no further clinical or outcome details.

Categories: public-health, science-and-space, positive-progress

Generated scores

Scores are based on the cited reporting and use a 1–10 scale. Read the methodology.

Confidence: 5/10How certain the assessment is based on the clarity and evidence in the cited reporting.
Geographic reach: 1/10How widely the event reaches, from a local area (1) to worldwide impact (10).
Global importance: 2/10The event's broader significance, from limited importance (1) to major global importance (10).
Impact magnitude: 2/10The scale or severity of the real-world impact, from minor (1) to extreme (10).
Positivity: 6/10How harmful or beneficial the event is, from strongly harmful (1) to strongly positive (10).
Urgency: 1/10How time-sensitive the event is, from low urgency (1) to immediate attention needed (10).

Why it matters

The report documents a notable treatment outcome for a patient with advanced esophageal cancer.

Sources

Pathological complete response achieved in a patient with initially unresectable locally advanced esophageal squamous cell carcinoma via conversion therapy combining immunotherapy and chemotherapy: a case report

Report an issue